NDC 51662-1483

SOLU-MEDROL(R) METHYLPREDNISOLONE SODIUM SUCCINAT

Solu-medrol(r) Methylprednisolone Sodium Succinat

SOLU-MEDROL(R) METHYLPREDNISOLONE SODIUM SUCCINAT is a Intramuscular; Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Methylprednisolone Sodium Succinate.

Product ID51662-1483_99b3c99a-79d6-6c54-e053-2a95a90a28bc
NDC51662-1483
Product TypeHuman Prescription Drug
Proprietary NameSOLU-MEDROL(R) METHYLPREDNISOLONE SODIUM SUCCINAT
Generic NameSolu-medrol(r) Methylprednisolone Sodium Succinat
Dosage FormInjection, Powder, For Solution
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS
Marketing Start Date2019-12-14
Marketing CategoryNDA / NDA
Application NumberNDA011856
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NameMETHYLPREDNISOLONE SODIUM SUCCINATE
Active Ingredient Strength500 mg/4mL
Pharm ClassesCorticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 51662-1483-1

1 VIAL in 1 CARTON (51662-1483-1) > 4 mL in 1 VIAL
Marketing Start Date2019-12-14
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51662-1483-1 [51662148301]

SOLU-MEDROL(R) METHYLPREDNISOLONE SODIUM SUCCINAT INJECTION, POWDER, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA011856
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-14

Drug Details

Active Ingredients

IngredientStrength
METHYLPREDNISOLONE SODIUM SUCCINATE500 mg/4mL

Pharmacological Class

  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.